185 related articles for article (PubMed ID: 23743930)
1. Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.
Diaz Z; Aguilar-Mahecha A; Paquet ER; Basik M; Orain M; Camlioglu E; Constantin A; Benlimame N; Bachvarov D; Jannot G; Simard MJ; Chabot B; Gologan A; Klinck R; Gagnon-Kugler T; Lespérance B; Samson B; Kavan P; Alcindor T; Dalfen R; Lan C; Chabot C; Buchanan M; Przybytkowski E; Qureshi S; Rousseau C; Spatz A; Têtu B; Batist G
Mod Pathol; 2013 Nov; 26(11):1413-24. PubMed ID: 23743930
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of next-generation sequencing in colorectal cancers.
Kim TM; Lee SH; Chung YJ
World J Gastroenterol; 2013 Oct; 19(40):6784-93. PubMed ID: 24187453
[TBL] [Abstract][Full Text] [Related]
3. Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.
Bins S; Cirkel GA; Gadellaa-Van Hooijdonk CG; Weeber F; Numan IJ; Bruggink AH; van Diest PJ; Willems SM; Veldhuis WB; van den Heuvel MM; de Knegt RJ; Koudijs MJ; van Werkhoven E; Mathijssen RH; Cuppen E; Sleijfer S; Schellens JH; Voest EE; Langenberg MH; de Jonge MJ; Steeghs N; Lolkema MP
Oncologist; 2017 Jan; 22(1):33-40. PubMed ID: 27662884
[TBL] [Abstract][Full Text] [Related]
4. Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.
Bruin SC; Klijn C; Liefers GJ; Braaf LM; Joosse SA; van Beers EH; Verwaal VJ; Morreau H; Wessels LF; van Velthuysen ML; Tollenaar RA; Van't Veer LJ
BMC Cancer; 2010 Dec; 10():662. PubMed ID: 21126340
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Liver Metastases: Does the Future of Precision Medicine Lie in Genetic Testing?
Barbon C; Margonis GA; Andreatos N; Rezaee N; Sasaki K; Buettner S; Damaskos C; Pawlik TM; He J; Wolfgang CL; Weiss MJ
J Gastrointest Surg; 2018 Jul; 22(7):1286-1296. PubMed ID: 29644557
[TBL] [Abstract][Full Text] [Related]
6. Analyzing the cancer methylome through targeted bisulfite sequencing.
Lee EJ; Luo J; Wilson JM; Shi H
Cancer Lett; 2013 Nov; 340(2):171-8. PubMed ID: 23200671
[TBL] [Abstract][Full Text] [Related]
7. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
[TBL] [Abstract][Full Text] [Related]
8. Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays.
Muñoz-Bellvis L; Fontanillo C; González-González M; Garcia E; Iglesias M; Esteban C; Gutierrez ML; Abad MM; Bengoechea O; De Las Rivas J; Orfao A; Sayagués JM
Mod Pathol; 2012 Apr; 25(4):590-601. PubMed ID: 22222638
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
10. The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.
Orjuela S; Menigatti M; Schraml P; Kambakamba P; Robinson MD; Marra G
BMC Cancer; 2020 Apr; 20(1):290. PubMed ID: 32252665
[TBL] [Abstract][Full Text] [Related]
11. A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
Ozawa T; Kandimalla R; Gao F; Nozawa H; Hata K; Nagata H; Okada S; Izumi D; Baba H; Fleshman J; Wang X; Watanabe T; Goel A
Gastroenterology; 2018 Mar; 154(4):844-848.e7. PubMed ID: 29199088
[TBL] [Abstract][Full Text] [Related]
12. Integration of genome scale data for identifying new players in colorectal cancer.
Sokolova V; Crippa E; Gariboldi M
World J Gastroenterol; 2016 Jan; 22(2):534-45. PubMed ID: 26811605
[TBL] [Abstract][Full Text] [Related]
13. Characterization of novel low passage primary and metastatic colorectal cancer cell lines.
Boot A; van Eendenburg J; Crobach S; Ruano D; Speetjens F; Calame J; Oosting J; Morreau H; van Wezel T
Oncotarget; 2016 Mar; 7(12):14499-509. PubMed ID: 26894854
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
[TBL] [Abstract][Full Text] [Related]
16. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
Furuki H; Yamada T; Takahashi G; Iwai T; Koizumi M; Shinji S; Yokoyama Y; Takeda K; Taniai N; Uchida E
Eur J Surg Oncol; 2018 Jul; 44(7):975-982. PubMed ID: 29452859
[TBL] [Abstract][Full Text] [Related]
18. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.
Patel LR; Nykter M; Chen K; Zhang W
Cancer Lett; 2013 Nov; 340(2):152-60. PubMed ID: 23111104
[TBL] [Abstract][Full Text] [Related]
19. Should next-generation sequencing testing be routinely used in metastatic colorectal cancer?
Dienstmann R; Ciner A; Hochster HS
Lancet Oncol; 2018 Nov; 19(11):1434-1435. PubMed ID: 30507475
[No Abstract] [Full Text] [Related]
20. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications.
Sho S; Court CM; Winograd P; Lee S; Hou S; Graeber TG; Tseng HR; Tomlinson JS
BMC Cancer; 2017 Jul; 17(1):457. PubMed ID: 28666423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
